Advisory Committees

Direction and advice regarding CADTH optimal use projects are provided through:

• Canadian Drug Expert Committee (CDEC)
• Drug Policy Advisory Committee (DPAC)
• DPAC Optimal Use Working Group

CADTH also develops expert review panels as required to support specific projects.  Information on these panels is available on the web pages relating to the projects. Examples include:

• Medical Isotopes and Imaging Modalities Advisory Committee (MIIMAC)
• CADTH MRI Expert Advisory Panel
• COMPUS Expert Review Panel on Proton Pump Inhibitors